Estia Health ( ) - 株価, ニュースと分析ASX:EHE

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

EHE 株式概要

Estia Health Limited provides residential aged care home services in Australia.

EHE fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	4/6
Past Performance	0/6
Financial Health	3/6
Dividends	2/6

報酬

当社が推定した公正価値より59%で取引されている

収益は年間66.96%増加すると予測されています

リスク分析

5.1%の配当は利益で十分にカバーされていない

Estia Health Limited 競合他社

Regis Healthcare

ASX:REG

AU$1.3b

Monash IVF Group

ASX:MVF

AU$516.3m

Pacific Smiles Group

ASX:PSQ

AU$301.6m

Ramsay Health Care

ASX:RHC

AU$11.2b

価格と性能

Summary of all time highs, changes and price drops for Estia Health
Historical stock prices
Current Share Price	AU$3.08
52 Week High	AU$3.14
52 Week Low	AU$1.93
Beta	0.96
1 Month Change	0.98%
3 Month Change	1.99%
1 Year Change	57.95%
3 Year Change	77.01%
5 Year Change	41.28%
Change since IPO	-35.02%

Recent updates

Estia Health (ASX:EHE) Takes On Some Risk With Its Use Of Debt

Feb 25

Here's Why We Think Estia Health Limited's (ASX:EHE) CEO Compensation Looks Fair

Nov 04

Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky

Apr 13

Has Estia Health (ASX:EHE) Got What It Takes To Become A Multi-Bagger?

Mar 08

What You Need To Know About Estia Health Limited's (ASX:EHE) Investor Composition

Feb 21

If You Had Bought Estia Health's (ASX:EHE) Shares Five Years Ago You Would Be Down 73%

Jan 24

株主還元

	EHE	AU Healthcare	AU 市場
7D	0%	4.3%	0.1%
1Y	57.9%	-20.2%	6.2%

業界別リターン: EHE過去 1 年間で-22.2 % の収益を上げたAustralian Healthcare業界を上回りました。

リターン対市場: EHE過去 1 年間で8.2 % の収益を上げたAustralian市場を上回りました。

価格変動

Is EHE's price volatile compared to industry and market?
EHE volatility
EHE Average Weekly Movement	0.6%
Healthcare Industry Average Movement	5.9%
Market Average Movement	8.4%
10% most volatile stocks in AU Market	15.9%
10% least volatile stocks in AU Market	3.2%

安定した株価: EHE過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: EHEの週次ボラティリティ ( 1% ) は過去 1 年間安定しています。

会社概要

設立	従業員	CEO（最高経営責任者	ウェブサイト
2005	8,220	Sean Bilton	www.estiahealth.com.au

Estia Health Limited 基礎のまとめ

Estia Health の収益と売上を時価総額と比較するとどうか。
EHE 基礎統計学
時価総額	AU$805.54m
収益（TTM）	-AU$33.90m
売上高(TTM)	AU$754.30m

1.1x

P/Sレシオ

-23.8x

PER（株価収益率

EHE は割高か？

公正価値と評価分析を参照

収益と収入

最新の決算報告書（TTM）に基づく主な収益性統計
EHE 損益計算書（TTM）
収益	AU$754.30m
売上原価	AU$584.82m
売上総利益	AU$169.48m
その他の費用	AU$203.37m
収益	-AU$33.90m

直近の収益報告

Jun 30, 2023

次回決算日

該当なし

一株当たり利益（EPS）	-0.13
グロス・マージン	22.47%
純利益率	-4.49%
有利子負債／自己資本比率	14.0%

EHE の長期的なパフォーマンスは？

過去の実績と比較を見る

配当金

5.1%

現在の配当利回り

-120%

配当性向

EHE 株式概要

報酬

リスク分析

Estia Health Limited 競合他社

ASX:REG

AU$1.3b

ASX:MVF

AU$516.3m

ASX:PSQ

AU$301.6m

ASX:RHC

AU$11.2b

価格と性能

最新ニュース

Estia Health Limited Announces Cessation of Helen Kurincic as Director

Consensus EPS estimates fall by 30%, revenue upgraded

New minor risk - Dividend sustainability

Estia Health Limited Announces Dividend, Payable on September 15, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 16%

Recent updates

Estia Health Limited Announces Cessation of Helen Kurincic as Director

Consensus EPS estimates fall by 30%, revenue upgraded

New minor risk - Dividend sustainability

Estia Health Limited Announces Dividend, Payable on September 15, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 16%

Estia Health Limited (ASX:EHE) entered into a binding agreement to acquire residential aged care homes in Benalla of Royal Freemasons Ltd.

Estia Health Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

Bain Capital Reportedly Moves to Sell Craigcare But Abandons Its Pursuit of Estia

Consensus EPS estimates fall by 15%

Price target increased by 12% to AU$2.83

Independent Non-Executive Chairman recently bought AU$52k worth of stock

Consensus EPS estimates fall by 22%, revenue upgraded

First half 2023 earnings released: AU$0.098 loss per share (vs AU$0.031 loss in 1H 2022)

Estia Health Limited to Report First Half, 2023 Results on Feb 21, 2023

CEO, MD & Director recently bought AU$106k worth of stock

Consensus forecasts updated

Estia Health Limited Announces Retirement of Mr. Steve Lemlin, Chief Financial Officer

Consensus estimates of losses per share improve by 51%

Estia Health Limited, Annual General Meeting, Nov 03, 2022

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Estia Health Limited Announces Appointment of Simon Willcock as Non-Executive Director Effective 1 September 2022

Estia Health Limited Appoints Sean Bilton as Director

Estia Health Limited to Report Fiscal Year 2022 Results on Aug 23, 2022

Consensus forecasts updated

Insufficient new directors

Estia Health Limited Announces Management Changes

Estia Health Limited announces resignation of Hon. Warwick L. Smith AO as director, effective 31 March 2022

Consensus forecasts updated

Estia Health (ASX:EHE) Takes On Some Risk With Its Use Of Debt

First half 2022 earnings: EPS misses analyst expectations

Estia Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 18, 2022

Consensus forecasts updated

Here's Why We Think Estia Health Limited's (ASX:EHE) CEO Compensation Looks Fair

Insufficient new directors

Full year 2021 earnings released: EPS AU$0.023 (vs AU$0.45 loss in FY 2020)

Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky

Price target increased to AU$2.15

Has Estia Health (ASX:EHE) Got What It Takes To Become A Multi-Bagger?

Price target raised to AU$1.94

First half 2021 earnings released: AU$0.02 loss per share (vs AU$0.055 profit in 1H 2020)

Estia Health Limited Not Declare Interim Dividend for the Six Months Ended December 31, 2020

What You Need To Know About Estia Health Limited's (ASX:EHE) Investor Composition

Estia Health Limited Reaches an Agreement to Settle the Shareholder Class Action Commenced Against It in July 2019

New 90-day high: AU$1.96

If You Had Bought Estia Health's (ASX:EHE) Shares Five Years Ago You Would Be Down 73%

Is Estia Health (ASX:EHE) Using Too Much Debt?

Estia Health Limited to Report Q2, 2021 Results on Feb 23, 2021

Have Insiders Been Buying Estia Health Limited (ASX:EHE) Shares?

New 90-day high: AU$1.63

New 90-day low: AU$1.36

New 90-day low: AU$1.37

Non-Executive Director recently bought AU$101k worth of stock

Price target lowered to AU$1.62

Earnings released

Estia Health Limited Determines Not to Declare A Final Dividend for Fiscal Year 2020

Did Estia Health Limited (ASX:EHE) Insiders Buy Up More Shares?

Is There Now An Opportunity In Estia Health Limited (ASX:EHE)?

Estia Health Limited(ASX:EHE) dropped from S&P/ASX 200 Index